HMS Capital Management, LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1689470
NASHVILLE, TN
Position in HALO
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$497,718
+$86,736 QoQ
Shares Held
6,359
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#390
of 666 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HMS Capital Management, LLC holds $1,294,264 across 2 Biotechnology names. HALO ranks #2 (38.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
2,520 | $796,546 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
This page
|
6,359 | $497,718 |
All Filings in HALO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $497,718 | 6,359 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $410,982 | 6,359 | Shares | Sole | 2026-04-22 | |
| No filing history on record for this holder in this stock. | ||||||